|
Current & future perspectives in psychiatric drug discovery
12th March 2009 |
|
Psychiatric diseases, such as anxiety,
depression and schizophrenia, remain a major cause of disability,
affecting 300 million people worldwide. Pharmacotherapy has had a major
impact on the management of those with psychiatric disorders, but the
associated side-effects, along with efficacy that is less than complete,
means that the need for safe and effective psychotherapeutic drugs remains
high. This symposium brings together experts across the breadth of research and development in this field and will provide talks covering both the current challenges and recent advances in the clinical setting including the application of new technologies as well as a number of case studies of important new approaches to treat psychiatric disorders. |
| What would you like to do? |
|
|
|
REGISTRATION NOW CLOSED |
|
|
| Home / Meetings / Membership / Student Bursaries / Administration / History of the SMR / SMR Award / Archive Material / Links / Contact Us |